Reference : Extended safety observations from denosumab administration in postmenopausal women fr...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/104041
Extended safety observations from denosumab administration in postmenopausal women from FREEDOM and FREEDOM extension trials
English
Brown, J. P. [ > > ]
Bone, H. G. [ > > ]
Chapurlat, R. [ > > ]
Libanati, C. [ > > ]
Brandi, M. L. [ > > ]
Czerwinski, E. [ > > ]
Krieg, M. A. [ > > ]
Man, Z. [ > > ]
Mellstrom, D. [ > > ]
Radominski, S. C. [ > > ]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Resch, H. [ > > ]
Roman Ivorra, J. A. [ > > ]
Roux, C. [ > > ]
Daizadeh, N. S. [ > > ]
Grauer, A. [ > > ]
Cummings, S. R. [ > > ]
Papapoulos, S. [ > > ]
2011
Arthritis and Rheumatism
Wiley Liss, Inc.
63
S10
431-432
Yes (verified by ORBi)
International
0004-3591
1529-0131
New York
NY
Vertex announces presentation of new data for oral JAK3 inhibitor VX-509
novembre 2011
Business Wire - Vertex Pharmaceuticals Incorporated
Chicago
USA
http://hdl.handle.net/2268/104041

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Extended Safety Observations From Denosumab Administration in Postmenopausal Women From the FREEDOM and FREEDOM Extension Trials.pdfPublisher postprint101.72 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.